BioCentury
ARTICLE | Finance

Ebb & Flow

September 24, 2007 7:00 AM UTC

Having chalked up a number of specialty pharma exits over the last few years, Domain Associates made another tidy exit last week, as urology and gynecology company Esprit is being acquired by Allergan (AGN) for $370 million in cash.

About $220 million in equity financing went into Esprit, Domain Partner Robert More told Ebb & Flow. Although the buyout fetched less than a 2X return, the investors got to cash out in just over two years...